|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
INTRODUCTION |
|---|
|
|
|---|
The paper by Oswald-Mammosser and colleagues (1) examines the effects of lung volume reduction surgery (LVRS) on
indices of lung volume/flow rates, hemodynamics, gas exchange and
O2 at rest and during exercise. At first sight, the
results appear rather modest
despite gains in FEV1 and in
peak
O2 during exercise that both reached nearly 40%, most
other variables failed to significantly improve. Thus, arterial
PO2, PCO2, AaPO2 difference, and pulmonary artery pressure
were all unchanged after LVRS, both at rest and during exercise. This differs, but only slightly, from other data which have
shown small improvements in arterial PO2 and PCO2, at least at
rest (2, 3).
In the paper under discussion, at constant submaximal power output, neither cardiac output nor minute ventilation were altered post-LVRS; unfortunately, data for these two key variables at peak exercise were not measured. Taken at face value, the paper might lead one to conclude that LVRS improves airflow and exercise capacity, but has no effect on gas exchange or pulmonary hemodynamics. Looking at the mean data, however, appears to obscure some important observations about how LVRS may affect not only lung mechanical properties, but also those pertaining to gas exchange and to blood flow in the lungs.
What catches the eye and leads to this assertion are strong
and distinctive correlations between certain pairs of variables, not all of which appear to be addressed in the paper. These
deserve some discussion, and may even merit some speculation. The data demonstrate that mean results of a group of patients undergoing a treatment do not tell the whole story
examination of individual data can be very revealing. These
relationships not only indicate that LVRS is indeed affecting
gas exchange and hemodynamics, they suggest possible physiologic mechanisms of change brought about by the surgery.
Some day they may even be of value in establishing patient selection criteria for LVRS.
Of the variables presented in the paper, FEV1 reflecting air
flow rates through the bronchial tree, and pulmonary artery
pressure (Ppa) symmetrically indicating vascular conductance
(at a particular level of blood flow) are of interest. There is a
strong relationship between gains in FEV1 and in
O2 peak after LVRS (r2 = 0.77), and between improvements in AaPO2
and reductions in Ppa after LVRS (r2 = 0.89). There is, however, little or no relationship between gains in FEV1 and reduction in Ppa (r2 = 0.05), gains in
O2 peak and fall in Ppa
(r2 = 0.21), or gains in FEV1 and fall in AaPO2 (r2 = 0.06).
These relationships are all shown in Figure 1.
|
There is, therefore, a neat separation between relationships
which link
O2 peak to FEV1, and those that link gas exchange to pulmonary hemodynamics with essentially no apparent interaction. The potential mechanistic implications of
these findings is the principal topic of this editorial, but first
the overall group data are briefly discussed.
| |
INTERPRETATION OF MEAN DATA |
|---|
|
|
|---|
The finding that FEV1 was the only reported physiologic variable to increase along with
O2 peak after LVRS suggests that the ability to increase ventilation during exercise was enhanced after surgery. In fact, the percentage gains in the two
variables were virtually the same (38% and 36%, respectively).
Constancy of arterial PCO2 with exercise before and after surgery further supports this notion in that along with the higher
O2 peak (and
CO2 peak), ventilation at peak
O2 was increased in rough proportion to metabolic rate. That this appears to have been the major reason for improved peak
O2 is
suggested by lack of change in arterial PO2 (and thus saturation) and the presumed constancy of hemoglobin levels. These
in turn imply no increase in arterial O2 concentration to augment peak
O2. We do not know what happened to peak cardiac output, but an educated guess is that it increased similarly
with
O2 peak, based on data that show the cardiac output-
O2 relationship closely follows that of normal subjects in patients with COPD (4). Such an increase in cardiac output
would likely be necessary for such a large increase in peak
O2 to occur
the Fick principle underlies this suggestion.
But the increase in peak
O2 would seem to hinge primarily
on the implied newfound ability to increase ventilation during
exercise. This concept is quite compatible with the work of
Benditt and colleagues (5) who in fact found that the increase
in peak
O2 post-LVRS could be attributed to improvement
in ventilation.
| |
INTERPRETATION OF BETWEEN-SUBJECT RELATIONSHIPS |
|---|
|
|
|---|
Not only do the mean group data point to increased ventilation
as the primary benefit of LVRS in terms of increasing
O2, the
strong correlation between peak
O2 and FEV1 subject by subject strengthens the argument (see Figure 1, top left panel).
Although gas exchange and hemodynamics both failed to improve as a whole, the data show that gas exchange improvement was closely related to changes in pulmonary artery pressure with an r2 of almost 0.9 over a wide range of both gas exchange and pressure (Figure 1, middle right panel). On the other hand, gas exchange was unrelated to changes in FEV1 (r2 = 0.06). This is good evidence that LVRS can affect gas exchange, and that improvement in gas exchange relates not to the ability to move air, but to the ability to move blood through the pulmonary circulation (in a manner that improves ventilation/perfusion matching). Note that LVRS had effects on both FEV1 and pulmonary artery pressure, but that these effects were completely unrelated (Figure 1, bottom panel). Thus, the gas exchange-pulmonary artery pressure relation is not just a correlation of effects of LVRS on FEV1. It seems to be an independent result.
Another relationship of interest was that between reductions (after LVRS) in arterial PCO2 and pulmonary artery pressure during exercise (r2 = 0.58). The relationship between changes in arterial PCO2 and FEV1 was nonexistent (r2 = 0.003). This further supports the notion that reduction in pulmonary arterial pressure after LVRS improves ventilation/perfusion relationships, although this conclusion would be stronger if maximal exercise ventilation values were, like FEV1, unrelated to arterial PCO2. Unfortunately, these data were not reported.
Both of the above gas exchange-pulmonary artery pressure
relationships in turn suggest that despite airway obstruction being the dominant physiological defect in COPD, perfusion and
its distribution are key to gas exchange inefficiency, and to
whether LVRS affects gas exchange. This can be nicely explained if LVRS preferentially removes poorly perfused areas
which have a high ventilation/perfusion (
A/
) ratio. It is well
known that even with adequate total ventilation, CO 2 retention
can occur when high
A/
areas exist ("physiological dead
space" or "wasted ventilation"). If these areas are removed, arterial P CO2 and AaPO2 should fall without change in total ventilation. Pulmonary vascular pressures can then fall as well if
these removed areas permit remaining, better perfused, but less
expanded lung regions to regain volume, and/or if the surgery
has preferentially removed high vascular resistance pathways.
| |
SUMMARY |
|---|
|
|
|---|
What have the data in this paper told us? First, a word of caution may be warranted. The relationships depicted in Figure 1 are seductively strong, but come from a small group of patients. Would the correlations be as good if the study were repeated? Hopefully yes, but possibly no. But if one allows the above mix of data analysis and speculation, the following conclusions may be offered:
O2 cannot be deduced from the present paper.
PETER D. WAGNER
Department of Medicine
University of California/San Diego
La Jolla, California
| |
References |
|---|
|
|
|---|
1.
Oswald-Mammosser, M.,
R. Kessler,
G. Massard,
J.-M. Wihlm,
E. Weitzenblum, and
J. Lonsdorffer.
1998.
Effect of lung volume reduction
surgery on gas exchange and pulmonary hemodynamics at rest and
during exercise.
Am. J. Respir. Crit. Care Med.
158:
1020-1025
2.
Sciurba, F. C.,
R. M. Rogers,
R. J. Keenan,
W. A. Slivka III,
J. Gorscan,
P. F. Ferson,
J. M. Holbert,
M. L. Brown, and
U. J. Landreneau.
1996.
Improvement in pulmonary function and elastic recoil after lung reduction surgery for diffuse emphysema.
N. Engl. J. Med.
334:
1095-1099
3.
Cooper, J. D.,
G. A. Patterson,
R. S. Sundaresan,
E. P. Trulock,
R. D. Yusen,
M. S. Pohle, and
S. S. Lefrak.
1996.
Results of 150 consecutive
bilateral lung volume reduction procedures in patients with severe
emphysema.
J. Thorac. Cardiovasc. Surg.
112:
1319-1330
4. Agusti, A. G. N., J. Roca, and P. D. Wagner. 1997. Responses to exercise in lung diseases. In J. Roca and B. Whipp, editors. European Respiratory Monography on Clinical Exercise Testing. Eur. Respir. J. 2(Monograph 6):32-50.
5.
Benditt, J. O.,
S. Lewis,
D. E. Wood,
L. Klima, and
R. K. Albert.
1997.
Lung volume reduction surgery improves maximal O2 consumption,
maximal minute ventilation, O2 pulse, and dead space-to-tidal volume
ratio during leg cycle ergometry.
Am. J. Respir. Crit. Care Med.
156:
561-566
6.
Gelb, A. F.,
R. J. McKenna,
M. Brenner,
R. Fischel,
A. Baydur, and
N. Zamel.
1996.
Contribution of lung and chest wall mechanics following
emphysema resection.
Chest
110:
11-17
7. Gelb, A. F., N. Zamel, R. J. McKenna, and M. Brenner. 1996. Mechanism of short-term improvement in lung function after emphysema resection. Am. J. Respir. Crit. Care Med. 154: 945-951 [Abstract].
This article has been cited by other articles:
![]() |
J.A. Barbera, V.I. Peinado, and S. Santos Pulmonary hypertension in chronic obstructive pulmonary disease Eur. Respir. J., May 1, 2003; 21(5): 892 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
ATS/ACCP Statement on Cardiopulmonary Exercise Testing Am. J. Respir. Crit. Care Med., January 15, 2003; 167(2): 211 - 277. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |